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Background: The medical literature shows that alcohol consumption is common among diabetic individuals and is
associated with poor adherence to treatment, resulting in increased morbidity and mortality. However, no study has
assessed the association between high-risk alcohol consumption and the presence of anxiety and depression in individuals
with type 1 diabetes mellitus (1DM).
Methods: The present cross-sectional study was conducted in Uberlândia, Brazil, and it assessed 209 outpatients
in relation to alcohol consumption and the presence of anxiety and depression symptoms, using the Alcohol
Use Disorders Identification Test (AUDIT), the Hospital Anxiety and Depression (HAD) scale, and glycemic control,
according to the levels of glycated hemoglobin (HbA1c). The chi-square test and logistic regression analysis
were used to investigate the association between the investigated variables.
Results: The prevalence of high-risk alcohol consumption (AUDIT ≥ 8) among individuals with 1DM was high,
specifically 24.9% among the entire group of subjects, 12.9% among the adolescents, 14.7% among the females,
and 34.6% among the males. In comparisons based on gender and age, the odds of high-risk drinking were higher
among males and participants aged 30 to 40 years (33.9%). The frequency of high-risk alcohol consumption did
not differ as a function of gender among adolescents (females: 9.0%, males: 16.2%; p = 0.374). There was a linear
trend in proportions related to the scores of anxiety and depression symptoms with high-risk alcohol consumption
scores, indicating the association of these variables (p = 0.0229 and p = 0.0262, respectively). Moreover, the odds of
female subjects exhibiting anxiety and depression symptoms were higher (odds ratio – OR: 4.4 and OR: 7.4, respectively).
Glycemic control did not exhibit an association between high-risk alcohol consumption and the presence of anxiety and
depression symptoms.
Conclusions: The frequency of high-risk drinking increased along with age and was greater among males; however, this
frequency did not exhibit differences in terms of gender among adolescents. There was a positive association between
high risk alcohol consumption and anxiety and depression symptoms, although glycemic control was inadequate in
most of the sample independent of alcohol consumption and the presence of anxiety and depression symptoms.
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The number of individuals with diabetes mellitus increases
every year and is estimated to reach 592 million by 2035,
with a faster increase expected in poor and developing
countries [1]. In Brazil, the number of individuals with
diabetes mellitus is estimated at 11.9 million, 5 to 10%
of which are type 1 diabetes mellitus (1DM) [1]. Studies
conducted in different parts of the world also show that
the incidence of 1DM among children and adolescents is
increasing [2].
The literature shows that the age at which alcohol
consumption begins is falling steadily among adolescents
and young adults, and therefore the risks associated with
alcohol abuse are affecting a younger population [3,4].
Studies conducted in Brazil have shown a high preva-
lence of frequent alcohol use (one to four times per
week) among adolescents (8%) and adults (24%) [5,6].
However, there are few studies on the frequency of alcohol
consumption by individuals with 1DM [7,8] as a whole,
and no studies have been conducted in Brazil.
Review studies indicate that the alcohol use is com-
mon among individuals with diabetes mellitus, and this
behavior is associated with poor adherence to treatment.
This association may result in negative outcomes [9],
including increased morbidity [10] and up to twofold
increases in mortality [11], besides being a risk factor
for trauma due to external causes [12-14].
The World Health Organization (WHO) recommends
the Alcohol Use Disorders Identification Test (AUDIT)
as a screening instrument [15] to allow early and effect-
ive treatment.
Several studies have found that the prevalence of de-
pression is two to three times higher among individuals
with diabetes mellitus compared to the overall popula-
tion; in regard to gender, this prevalence is also higher
among females than males. Although depression occurs
up to three times more frequently in adolescents with
1DM, the causes of this association remain unknown
[16,17]. Anxiety and depression may hinder proper gly-
cemic control, as one study found that individuals with a
positive screen for mental diseases had twice the odds of
having poor glycemic control compared to those without
them [18]. There are several factors such as age at diag-
nosis, diabetes mellitus duration and the type of treat-
ment that influence the glycemic control [19,20].
The aim of the present study was to investigate the de-
gree of alcohol consumption, the prevalence of anxiety
and depression symptoms, and the level of glycemic
control of adolescents and adults with 1DM who were
followed by an endocrinology outpatient clinic.
Methods
The present cross-sectional study was conducted at the
outpatient clinics of the Federal University of Uberlândiaand the Municipal Center for Diabetics’ Care of Uberlândia.
These centers are located in Southeastern Brazil, and
participants were interviewed from November 2011 to
October 2012. This study used a convenience sample
and was approved by the research ethics committee of
the Federal University of Uberlândia (no. 251/2011)
and the Municipal Health Secretary of Uberlândia. Diagnosis
of 1DM was established based on the criteria formulated by
the American Diabetes Association (ADA) [21]. The data
were collected by one of the investigators during individual
interviews conducted in a private room. During these
interviews, demographic data were collected using a
form, the AUDIT instruments and the Hospital Anxiety
and Depression (HAD) scale were applied. All of the
participants, or their parents or guardians in case individ-
uals were younger than 18 years, signed an informed con-
sent form. In addition, adolescents signed an information
letter, as requested by the research ethics committee of
the Federal University of Uberlândia. The inclusion
criteria consisted of a diagnosis of 1DM according to
ADA criteria [21], age of 14 to 40 years, and consent
to participate. The age of 14 was set as the minimum,
based on the study that validated the HAD in Brazil
[22,23]. The exclusion criteria were schizophrenia; bipolar
disorder; heart, liver, or kidney failure; cognitive deficit; or
other diseases that could impair the data interpretation.
Characteristics of the case series
The following data were recorded: age (14–19, 20–29,
and 30–40), gender, marital status, educational level,
current smoker, use of illegal drugs, presence of comorbidi-
ties, and family history of alcohol use. As all the patients
are 1DM they were using insulin. The subject’s educational
level was categorized as less than 8 years or more than
8 years of formal schooling. In regard to the participants’
marital status, we considered subjects without a partner as
single and those legally married or in stable unions as
married.
Instrument to assess the degree of alcohol use
AUDIT was used to assess alcohol use; this scale was for-
mulated by the WHO [15] and translated and validated in
Brazil [24] and in adolescents [25-27]. AUDIT is an
international instrument that was developed to screen
high-risk drinking based on the measurement of alcohol
consumption, personal and social consequences, and alco-
hol dependence in the past 12 months. Based on their
total scores, the participants were classified in one of four
possible risk categories: scores up to 7 indicated low-risk
drinking; 8 to 15, hazardous drinking; 16 to 19, harmful
drinking; and over 20, possible alcohol dependence [15].
On these grounds, a score of 8 points was selected as the
cutoff value for defining high-risk alcohol use, as this
value was shown to exhibit 100% sensitivity and 76%
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72% in the case of adolescents [27]. Individuals who
reported no alcohol consumption in the past year were
considered abstemious [28].
Instrument to assess anxiety and depression
symptoms - HAD
HAD comprises 14 items: 7 assessing anxiety (HAD-A)
and 7 assessing depression (HAD-D). Each item can be
scored from 0 to 3, and the highest total score in each
subscale is thus 21. The cutoff point selected in the
present study to define the frequency of anxiety and de-
pression symptoms as positive was a score of 8 points,
as this value exhibited satisfactory sensitivity and specifi-
city in both the anxiety (74% and 74.2%, respectively) and
the depression (85.7% and 72.4%, respectively) subscales
in the validation study conducted in Brazil [22].
Assessment of glycemic control
The data related to glycated hemoglobin (HbA1c) values
during the study period were collected from the partici-
pants’ clinical records. HbA1c was measured by means
of the immunoturbidimetric method (kits by laboratories
ABBOT and Roche, and Architect C 8000 and Cobas
6.000 equipment; reference value: 4.0% to 6.0%). Values
lower than 7.0% in adults and lower than 7.5% in adoles-
cents represented good glycemic control; values ranging
from 7.0 to 9.0% in adults and from 7.5 to 9.0% in adoles-
cents represented moderate glycemic control; and values
over 9.0% were considered poor glycemic control [29].
Statistical analysis
The association between qualitative dichotomous variables
was assessed by means of the two binomial proportions or
the chi-square (χ2) test, and those that exhibited statistical
significance were subjected to multiple logistic regression
analysis, in which alcohol consumption was the dependent
variable; these results were expressed as the odds ratio (OR).
In the chi-square (χ2) test continuity correction was used
whenever the expected frequency was less than 5. Nominal
variables with more than two categories were analyzed by
means of multiple comparison tests for proportions.
It was used the Cochran-Armitage trend test, some-
times also referred to as the trend on proportions test,
allows to test if a series of proportions (or the corre-
sponding counts, stored in Rx2 contingency table), can
be considered as varying linearly with an ordinal or
continuous score variable. It is related to the Chi-square
independence test that allows to test if there is rela-
tionship between the rows and the columns of a con-
tingency table. The Cochran-Armitage test allows you
to take into account a ranking among the rows, based
on scores [30]. Statistical analyses were performed usingBioEstat 5.0 software [31] and R 2.6.1 for Windows® [32]
and JMP® 2000 [33]. The significance level was set at 5.0%.
Results
The group of individuals with 1DM treated at the out-
patient clinics of the Federal University of Uberlândia
and the Municipal Center for Diabetics’ Care within the
investigated age range included 427 patients. A total of
221 consecutive patients were invited to participate in
the study, although 6 (2.7%) refused to participate, and 6
were excluded, including 4 (1.8%) due to cognitive deficit
and 2 (0.9%) to kidney failure. Approximately 97.0% of
the initial sample agreed to participate, and 94.6% remained
in the study after application of the exclusion criteria. The
final sample thus comprised 209 individuals with 1DM.
The median age of the sample was 23 years old.
Males constituted 51.0% of the sample, and there was
no significant gender difference (p = 0.6248). In addition,
69.0% of the subjects were single, and 88.0% had attended
formal schooling for at least 8 years (Table 1).
Approximately 9.0% of the participants were current
smokers, and 12.0% used illegal drugs. In approximately
64.0% of subjects, the time elapsed since the diagnosis of
1DM was longer than 5 years. The level of HbA1c was
very high (≥9.0%) in most of the participants (52.6%),
and 72.2% showed a positive family history of alcohol
consumption (Table 2).
High-risk alcohol use was greater among males aged 30
to 40, although this variable did not exhibit a significant
difference between genders among adolescents (p = 0.374)
(Table 3).
Table 4 shows that the prevalence of high-risk alcohol use
(AUDIT ≥8) was greater among males, the oldest age range,
users of illegal drugs, current smokers, and participants with
a positive family history of alcohol consumption.
Among the participants classified as high-risk drinkers,
29.0% (IC 95%: 0.7-2.6) exhibited anxiety symptoms and
34.8% (IC 95%: 0.7-4.3) depression symptoms. There was
a linear trend in proportions related to the scores of
anxiety and depression symptoms with high-risk alcohol
consumption scores, indicating the association of these
variables (p = 0.0229 and p = 0.0262, respectively), data
not shown in table.
Table 5 shows that the odds of exhibiting anxiety
symptoms were 2.0 times higher among females com-
pared to males (IC 95%: 1.1-3.8), while no difference was
found when age was considered. The odds of drug users
exhibiting anxiety symptoms were also 2.5 times higher
compared to non-users (IC 95%: 1.1-5.8). Moreover, the
presence of anxiety symptoms exhibited an association
with the presence of depressive symptoms but not with
glycemic control (Table 5).
The odds of women exhibiting symptoms of depression
were 4.4 higher compared to men (IC 95%: 1.6-12.3), and
Table 2 Clinical characteristics of the participants
Variables Female (n = 102) Male (n = 107) Total (n = 209)
n % n % n %
High-risk alcohol use AUDIT ≥8
Yes 15 14.7 37 34.6 52 24.9
No 87 85.3 70 65.4 157 75.1
Anxiety symptoms HAD-A ≥8
Yes 38 37.2 24 22.4 62 29.7
No 64 62.7 83 77.6 147 70.3
Depression symptoms HAD-D ≥8
Yes 18 17.6 5 4.7 23 11.0
No 84 82.3 102 95.3 186 89.0
Current smoker
Yes 05 04.9 14 13.1 19 9.1
No 97 95.1 93 86.9 190 90.9
Drug use
Yes 04 3.9 21 19.6 25 12.0
No 98 96.1 86 80.4 184 88.0
Time since diagnosis of 1DM
≤5 years 35 34.3 41 38.3 76 36.4
>5 years 67 65.7 66 61.7 133 63.6
Parental alcohol use
Yes 76 74.5 75 70.1 151 72.2
No 26 25.5 32 29.9 58 27.7
HbA1c
Good control 7 6.9 12 11.2 19 9.1
Moderate control 39 38.2 41 38.3 80 38.3
Poor control 56 54.9 54 50.5 110 52.6
AUDIT: Alcohol Use Disorders Identification Test; HAD-A: Hospital Anxiety
and Depression– anxiety subscale; HAD-D: Hospital Anxiety and Depression–
depression subscale.
Table 1 Socio- demographic characteristics of individuals with type 1 diabetes
Variables Female (n = 102) Male (n = 107) p-value Total (n = 209)
n % n % n %
Age range (n = 209)
14 [−] 19 years old 33 32.3 37 34.6 0,733 70 33.5
20 [−] 29 years old 36 35.3 47 43.9 0,202 83 39.7
30 [−] 40 years old 33 32.3 23 21.5 0,076 56 26.8
Marital status
Married 38 37.2 27 25.2 0,061 65 31.1
Single 64 62.7 80 74.8 0,061 144 68.9
Educational level
<8 years 12 11.8 14 13.1 0,772 26 12.4
≥8 years 90 88.2 93 86.9 0,772 183 87.6
Knychala et al. Diabetology & Metabolic Syndrome  (2015) 7:24 Page 4 of 8the odds of adults exhibiting such symptoms were 7.4 higher
compared to the other age ranges (IC 95%: 2.0-27.5).
In addition, smoking increased the risk of depression
by 6.3-fold (IC 95%: 2.2-18.4) (Table 6).
Discussion
The present study found high prevalence of high-risk
drinking among adolescents and adults with 1DM. In
particular, this prevalence was greater in males and older
participants but there was no gender difference among
adolescents. This present study results concerning the
prevalence of high-risk drinking among individuals with
diabetes mellitus are similar to those previously reported
for the overall Brazilian [34-36] and the United States
[37,38] population.
Although no previous studies have assessed the preva-
lence of alcohol use among individuals with 1DM in
Brazil, studies conducted in Chile and Ireland found
prevalence rates varying from 7% to 30.1% [7,8]. Such
wide variation is likely due to the use of different tools
and terminologies used to diagnose alcohol consump-
tion, as well as differences in the population age assessed
and the study setting.
In our study, in contrast to females, the proportion of
abstemious individuals was greater among males (22.4%)Table 3 Comparison of high-risk alcohol use (AUDIT ≥8)
between genders per age range
Female Male
Age range
years (n = 209)
AUDIT (n = 15)
Female (n = 102)
% AUDIT (n = 37)




3/33 9.1 6/37 16.2 0.374
20[−]29
(n = 83)
6/36 16.7 18/47 38.3 0.031
30[−]40
(n = 56)
6/33 18.2 13/23 56.5 0.0029
AUDIT: Alcohol Use Disorders Identification Test; p≤ 0.05.
Table 4 Prevalence of high-risk alcohol use according to the variables examined
Variables High-risk alcohol use (AUDIT ≥ 8)
AUDIT (n = 52)
Total (n = 209)
% Crude OR 95%CI p-value Adjusted OR 95%CI p-value
Gender
Female 15/102 14.7 1
Male 37/107 34.6 3.1 1.5-6.0 0.0009 2.8 1.3-6.2 0.0108
Age range (years)
14[−]19 9/70 12.9 1 a#
20[−]29 24/83 28.9 2.8 1.2-6.4 ab#
30[−]40 19/56 33.9 3.5 1.4-8.5 b# 1.1 1.0-1.1 0.0135
FH (alcohol use)
No 6/58 10.3 1
Yes 46/151 30.5 3.8 1.5-9.5 0.00259 7.0 2.2-2.5 0.0010
Drug use
No 35/184 19.0 1
Yes 17/25 68.0 9.0 3.6-22.6 <0.0001 5.9 1.9-17.9 0.0017
Current smoker
No 38/190 20.0 1
Yes 14/19 73.7 11.2 3.8-33.0 <0.0001 8.2 2.2-30.6 0.0016
HbA1c
Good control 4/19 21.0 1
Moderate control 22/80 27.5 1.4 0.4-4.8
Poor control 26/110 23.6 1.2 0.3-3.8 0.7658 NS
AUDIT: Alcohol Use Disorders Identification Test; FH: family history; p ≤ 0.05; # proportions followed by the same letter do not differ. HbA1c: glycated hemoglobin;
OR: Odds Ratio; CI: confidence interval.
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Silveira [28] in a study conducted in Brazil with 1,464 partic-
ipants. According to the literature, alcohol consumption is
greater among males, although we observed similarities in
this prevalence between genders among adolescences, which
corroborates previous findings [28,39].
Our results revealed that alcohol consumption increased
with age. This finding agrees with the results of a study
conducted in Chile, which found that the rate of alcohol
consumption by older adolescents was higher than that
observed in the younger [8]. Other authors have reported
that the onset of alcohol use at the beginning of adoles-
cence is associated with a greater frequency of abuse and
future dependence [40].
Self-care is a fundamental factor in the treatment of
diabetes mellitus, and alcohol consumption might be
considered a marker of risk for non-adherence to treat-
ment, which results in patients being less prone to seek
routine care [9]. The rate of anxiety symptoms found in
the present study (29.7%) is higher than that reported
for the overall population in a recent study (19.9%) [41]
as well as that reported by a study conducted on diabetic
individuals (21.3%) [18]; however, our rate of anxiety
symptoms was similar to that reported by another studyalso conducted with diabetic individuals (32%) indicating
that high risk drinkers are more prone to anxiety and
depression symptoms [7]. The frequency of anxiety and
depression symptoms was also higher among females,
which agrees with the results of studies conducted on
diabetic individuals [7,42] or the overall population [43].
In addition, the frequency of depression symptoms we
found was similar to that reported for the overall popu-
lation [41] and diabetic individuals [18].
The association between anxiety and depression symp-
toms observed in our sample of individuals with diabetes
is in agreement with previous reports in the literature.
Moreover, this association has been correlated with
lower rates of adherence to treatment, greater severity of
depression, and eventually with greater mortality [44,45].
In more than half of the participants in our study, the
HbA1c level was ≥9%, which is indicative of poor con-
trol of diabetes mellitus, and this finding agrees with the
results reported by other authors [46,47]. However, dif-
ferent from other studies [48], we did not detect an asso-
ciation between glycemic control and high-risk alcohol
use. The reason for this observation was most likely
because of the small number of participants who exhibited
good glycemic control (the HbA1c level was <7% in only
Table 6 Prevalence of depression symptoms according to
the variables examined
Variables Depression symptoms – HAD-D ≥8
Depression (n = 23)/
Total (n = 209)
% OR 95% CI p-value
Gender
Male 5/107 4.7 1
Female 18/102 17.6 4.4 1.6-12.3 0.0027
Age range (years)
14[−]19 3/70 4.3 1 a#
20[−]29 6/83 7.2 1.7 0.4-7.2 a#
30[−]40 14/56 25.0 7.4 2.0-27.5 b#
Current smoker
No 16/190 8.4 1
Yes 7/19 30.8 6.3 2.2-18.4 0.00016
HbA1c
Good control 1/19 5.3 1 a#
Moderate control 8/80 10.0 2.0 0.2-17.0 a#
Poor control 14/110 12.7 2.6 0.3-21.2 a#
HAD-D: Hospital Anxiety and Depression – depression subscale; p≤ 0.05; # proportions
followed by the same letter do not differ. HbA1c: glycated hemoglobin;
OR: odds ratio; CI: confidence interval.
Table 5 Prevalence of anxiety symptoms according to the
variables examined
Variables Anxiety symptoms – HAD-A ≥8
Anxiety (n = 62)/
Total (n = 209)
% OR 95% CI p-value
Gender
Male 24/107 22.4 1
Female 38/102 37.2 2.0 1.1-3.8 0.019
Age range (years)
14[−]19 17/70 24.3 1 a#
20[−]29 21/83 25.3 1.1 0.5-2.2 a#
30[−]40 24/56 42.7 2.3 1.1-5.0 a#
Drug use
No 50/184 27.2 1
Yes 12/25 48.0 2.5 1.1-5.8 0.0324
HAD-D
No depression 43/186 23.1 1
Depression 19/23 82.6 15.8 2.4-11.0 <0.0001
HbA1c
Good control 3/19 15.8 1 a#
Moderate control 23/80 28.7 2.1 0.6-8.1 a#
Poor control 36/110 32.7 2.6 0.7-9.5 a#
HAD-A: Hospital Anxiety and Depression – anxiety subscale; p ≤ 0.05; # proportions
followed by the same letter do not differ. HbA1c: glycated hemoglobin; OR: odds
ratio; CI: confidence interval.
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eventual presence of other factors that exert an influence
on glycemic control, such as the length of diabetes melli-
tus, age, use of medication, adherence to treatment, family
conflict, anxiety, and depression [47,49-51]. Moreover,
glycemic control did not exhibit an association with
the presence of anxiety symptoms, thus disagreeing
with the findings of other authors [7,52].
The results of our logistic regression analysis agree with
those studies that emphasized the wide variety of variables
that might influence alcohol consumption, including
family and environmental factors, depression, anxiety,
smoking, and the use of illegal drugs [40,53-61].
The proportion of current smokers in the present
study was lower than that previously reported by studies
conducted in the overall population [62] and diabetic in-
dividuals [8]. Nevertheless, this prevalence remains far
from the desired level, as no diabetic individual should
smoke because tobacco use is associated with a substantial
increase in the complications of this disease, particularly
those related to the cardiovascular, renal and neurological
systems [29].
The frequency of a positive family history of alcohol
consumption was high in the assessed sample, which
suggests that the influence exerted by the family relative
to high-risk drinking is strong. Living with both parents
and sharing at least one meal with parents or guardians
most days of the week have been shown to protect
against high-risk drinking; in addition, accurate know-
ledge of what adolescents do in their free time has a pro-
tective effect against the risk of smoking and the use of
alcohol and drugs [40,53]. The frequency of the use of
illegal drugs was high in the present sample, which
agrees with the result reported by a review study con-
ducted on the overall population of the United States [63].
Clinical implications of the study
Patients with diabetes mellitus who are high-risk drinkers
exhibit more frequent and severe health problems. The
American Academy of Pediatrics recommends investigat-
ing depression and alcohol use in all adolescents, and the
ADA emphasizes the specific relevance of such assess-
ment for the diabetic population [29,37,64]. Our study
stresses the need for healthcare professionals to identify
high-risk alcohol consumption and to promote a type of
follow up that ensures successful glycemic control.
Study strengths
Validated screening tests are useful for the identifica-
tion of patients who might benefit from early diagnosis
and treatment and for diabetic individuals who are at
high risk for alcohol consumption and the presence of
comorbidities, such as anxiety and depression. Further
studies with larger samples and in other geographical
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results. Longitudinal studies are indispensable to inves-
tigate the causal relations among these factors, as well
as to assess the effectiveness of interventions aiming at
improving glycemic control in this population.
Study limitations
The present study exhibited limitations inherent to cross-
sectional studies, in which causal factors and directions
cannot be assessed. Another limitation derived from the
fact that the present study was conducted at a reference
center and used a convenience sample. For these reasons,
the data could not be extended to other settings, such as
primary care, or to other geographical areas.
Conclusions
The prevalence of high-risk alcohol consumption and
symptoms of anxiety and depression was high in the
assessed sample of adolescents and adults with 1DM.
The frequency of high-risk drinking increased with age,
and its prevalence was greater among males; however,
differences in prevalence were not significant between
genders in adolescents. There was a positive association
between high risk alcohol consumption and anxiety and
depression symptoms, although glycemic control was
inadequate in most of the sample independent of alcohol
consumption and the presence of anxiety and depression
symptoms.
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